0
Business
How Pfizer's Oncology Portfolio Is Shaping Up Before Q1 Results
April 12, 2026
Quartz
Scroll
Pfizer's oncology unit displays mixed Q1 trends as key drugs and biosimilars offset Ibrance declines ahead of earnings on May 5
Quartz
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left